McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a February 19, 2014 edition of Law360.com in an article entitled, “USPTO Can’t Be Blamed For Patent On ‘Fraud’ Stem Cells.” The U.S. Patent and Trademark Office’s decision to issue a human stem cell patent to a scientist found years ago to have fabricated his work may seem like sloppy work by the agency, but attorneys say the office doesn’t have the ability to test the bona fides of an invention, nor does it need to in a system that renders fraudulent patents unenforceable. View the article